General Information of the Compound
| Compound ID |
CP0096672
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one
4,4a,5,6-Tetrahydro-3H-benzo[c]quinolizine-3-one
4,4a,5,6-Tetrahydro-pyrido[1,2-a]quinolin-3-one
BDBM50072192
CHEMBL99448
LNTWPSKEEYNUKK-UHFFFAOYSA-N
SCHEMBL6940070
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H13NO
|
||||||||||||||||||
| Molecular Weight |
199.253
|
||||||||||||||||||
| Canonical SMILES |
O=C1CC2CCc3ccccc3N2C=C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H13NO/c15-12-7-8-14-11(9-12)6-5-10-3-1-2-4-13(10)14/h1-4,7-8,11H,5-6,9H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
LNTWPSKEEYNUKK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound